You are here

lung cancer

ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer

ESMO: AstraZeneca wows with Imfinzi's 11-month survival edge in lung cancer

Fierce Pharma

Flag link:

ESMO: Merck piles on the positive Keytruda-chemo combo results in lung cancer

ESMO: Merck piles on the positive Keytruda-chemo combo results in lung cancer

Fierce Pharma

Flag link:

Can Pfizer Bank on New Immunotherapy Bavencio for Growth?

Can Pfizer Bank on New Immunotherapy Bavencio for Growth?

Yahoo/Zacks.com

immuno-oncology

renal cell carcinoma

head and neck cancer

Flag link:

The Fastest Growing Cancer Company You've Never Heard Of

The Fastest Growing Cancer Company You've Never Heard Of

Motley Fool

tumor treating fields

pancreatic cancer

Flag link:

For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand

For AstraZeneca, Cancer Drug Weighs on Go-It-Alone Stand

FOX Business

Flag link:

ASCO17: Roche's Alecensa bests Xalkori in lung study

ASCO17: Roche's Alecensa bests Xalkori in lung study

BioPharma Dive

Flag link:

Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer

Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer

Fierce Pharma

Flag link:

How Did Bristol Lose An Edge In Lung Cancer? It's No Mystery, Says New R&D Boss

How Did Bristol Lose An Edge In Lung Cancer? It's No Mystery, Says New R&D Boss

Forbes

Bristol-Myers Squibb

Flag link:

Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer

Novartis' targeted meds Tafinlar, Mekinist pick up EU combo approval in lung cancer

Fierce Pharma

Flag link:

Study: Why even targeted lung cancer therapies eventually fail

Study: Why even targeted lung cancer therapies eventually fail

Drug Delivery Business News

Flag link:

Heat Biologics Lung Cancer Combo Succeeds

Heat Biologics Lung Cancer Combo Succeeds

Investopedia

Bristol-Myers Squibb

Flag link:

Marketers take a new approach to lung-cancer campaigns, and why that matters

Marketers take a new approach to lung-cancer campaigns, and why that matters

Medical Marketing and Media

DTC advertising

Flag link:

Bristol-Myers shares drop after company says it will not seek fast-track drug approval

Bristol-Myers shares drop after company says it will not seek fast-track drug approval

CNBC

Bristol-Myers Squibb

Flag link:

Bristol-Myers Falls Further Behind Merck in Lung Cancer Race

Bristol-Myers Falls Further Behind Merck in Lung Cancer Race

Bloomberg

Bristol-Myers Squibb

Flag link:

Lilly Jumps After Lung Cancer Drug Patent Upheld

Lilly Jumps After Lung Cancer Drug Patent Upheld

Bloomberg

Teva Pharmaceutical

Flag link:

Merck shares rise after hours on priority review lung cancer drug application

Merck shares rise after hours on priority review lung cancer drug application

Marketwatch

priority review

Flag link:

Heat Biologics stock active on heels of lung, bladder cancer results

Heat Biologics stock active on heels of lung, bladder cancer results

Bizjournals.com

Flag link:

Fidel Castro-Supported Lung Cancer Vaccine To Be Tested In U.S. Clinical Trials

Fidel Castro-Supported Lung Cancer Vaccine To Be Tested In U.S. Clinical Trials

Forbes

clinical trials

Flag link:

Roche's lung cancer drug wins U.S. approval

Roche's lung cancer drug wins U.S. approval

Yahoo/Reuters

non-small cell lung cancer

Flag link:

How a Merck cancer breakthrough caused Bristol-Myers’ stock to plunge

How a Merck cancer breakthrough caused Bristol-Myers’ stock to plunge

Marketwatch

Bristol-Myers Squibb

Flag link: